デフォルト表紙
市場調査レポート
商品コード
1800865

アテレクトミー装置の市場レポート:製品別、用途別、エンドユーザー別、地域別、2025~2033年

Atherectomy Devices Market Report by Product Application, End User, and Region 2025-2033


出版日
発行
IMARC
ページ情報
英文 137 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.52円
アテレクトミー装置の市場レポート:製品別、用途別、エンドユーザー別、地域別、2025~2033年
出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のアテレクトミー装置の市場規模は、2024年に10億2,240万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに15億2,450万米ドルに達し、2025~2033年にかけて4.31%の成長率(CAGR)を示すと予測しています。末梢動脈疾患(PAD)の増加、大幅な技術発展、高齢者人口の増加、低侵襲手術の台頭、医療インフラ開発、新興経済諸国における償還政策などが、市場の成長を促す主な要因となっています。

アテレクトミー装置市場の動向

末梢動脈疾患(PAD)患者の増加

人口の高齢化、糖尿病や肥満の増加により、世界的にPADの症例が増加しており、アテレクトミー装置市場の成長を牽引しています。米国では約800万~1,200万人がPADに罹患しており、特に50歳以上の患者が多く、40歳以上の650万人がPADと診断されています。アテレクトミー装置は、血管介入における重要な代替手段であるため、動脈プラークを除去するための低侵襲アプローチを提供します。この装置は血流を促進し、脚の痛みや疲労などの症状を軽減します。プラークを直接切断または蒸発させることで、動脈開存性を回復させ、重度のPAD患者の予後を大幅に改善します。

技術の進歩

アテレクトミー装置の技術革新には、方向制御機器や高周波回転技術の登場があり、これらの機器の有効性と安全性を向上させています。例えば、2020年の研究によると、軌道式アテレクトミー(プラークを研磨して除去する方法)は、閉塞した脚の動脈を90%の確率で効果的に開通させる一方、レーザーアテレクトミーは76%の確率で同様に血流を改善するとされています。このような患者予後の改善と外科医によるこれらの器具の嗜好が、アテレクトミー装置の成長を後押ししています。172人の患者を対象とした多施設共同研究において、ジェットストリームの使用は99%の成功率を示し、6ヵ月後および12ヵ月後の臨床的な標的病変の再灌流率はそれぞれ15%および26%でした。

新興市場への進出

市場の主要プレーヤーは、医療インフラ開発と医療支出の増大が注目される新興経済諸国に注目しており、それによって新たな機会がもたらされています。例えば、ブラジル、ロシア、インド、中国、南アフリカ(BRICS)の新興市場は、世界の医療分野における医療品とサービスの需要と供給の状況をますます形成しつつあります。2030年のGDPに占める医療支出の割合は、ブラジル8.4%、ロシア5.2%、インド3.5%、中国5.9%、南アフリカ10.4%と予測されています。より高度な治療の選択肢の実現によりこれらの市場への参入が可能になり、アテレクトミー装置の世界的な展開が拡大します。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のアテレクトミー装置市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:製品別

  • 方向制御型アテレクトミー装置
  • 軌道式アテレクトミー装置
  • フォトアブレーションアテレクトミー装置
  • 回転式アテレクトミー装置
  • サポート装置

第7章 市場内訳:用途別

  • 末梢血管
  • 心血管
  • 神経血管

第8章 市場内訳:エンドユーザー別

  • 病院
  • 外来手術センター
  • 研究室および学術機関

第9章 市場内訳:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Avinger
    • B. Braun Melsungen AG
    • Biomerics
    • Biotronik
    • Boston Scientific Corporation
    • C.R. Bard(Becton, Dickinson and Company)
    • Cardinal Health Inc.
    • Koninklijke Philips N.V.
    • Medtronic
    • Minnetronix Inc.
    • Straub Medical AG(Becton, Dickinson and Company)
    • Terumo Corporation
図表

List of Figures

  • Figure 1: Global: Atherectomy Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Atherectomy Devices Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Atherectomy Devices Market: Breakup by Product (in %), 2024
  • Figure 4: Global: Atherectomy Devices Market: Breakup by Application (in %), 2024
  • Figure 5: Global: Atherectomy Devices Market: Breakup by End User (in %), 2024
  • Figure 6: Global: Atherectomy Devices Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 8: Global: Atherectomy Devices (Directional Atherectomy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Atherectomy Devices (Directional Atherectomy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Atherectomy Devices (Orbital Atherectomy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Atherectomy Devices (Orbital Atherectomy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Atherectomy Devices (Photo-Ablative Atherectomy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Atherectomy Devices (Photo-Ablative Atherectomy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Atherectomy Devices (Rotational Atherectomy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Atherectomy Devices (Rotational Atherectomy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Atherectomy Devices (Support Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Atherectomy Devices (Support Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Atherectomy Devices (Peripheral Vascular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Atherectomy Devices (Peripheral Vascular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Atherectomy Devices (Cardiovascular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Atherectomy Devices (Cardiovascular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Atherectomy Devices (Neurovascular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Atherectomy Devices (Neurovascular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Atherectomy Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Atherectomy Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Atherectomy Devices (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Atherectomy Devices (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Atherectomy Devices (Research Laboratories and Academic Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Atherectomy Devices (Research Laboratories and Academic Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia Pacific: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia Pacific: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Global: Atherectomy Devices Industry: SWOT Analysis
  • Figure 79: Global: Atherectomy Devices Industry: Value Chain Analysis
  • Figure 80: Global: Atherectomy Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Atherectomy Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Atherectomy Devices Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Atherectomy Devices Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Atherectomy Devices Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Atherectomy Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Atherectomy Devices Market: Competitive Structure
  • Table 7: Global: Atherectomy Devices Market: Key Players
目次
Product Code: SR112025A2766

The global atherectomy devices market size reached USD 1,022.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,524.5 Million by 2033, exhibiting a growth rate (CAGR) of 4.31% during 2025-2033. The rise in peripheral artery disease (PAD), significant technological advancements, rising ageing population, advent of minimally invasive surgeries, development of healthcare infrastructure, and reimbursement policies in emerging economies represent some of the key factors driving the growth of the atherectomy market.

Atherectomy Devices Market Trends:

Rising Cases of Peripheral Artery Disease (PAD)

The increasing cases of PAD at a global level due to ageing population and the rise in diabetes and obesity is leading the atherectomy device market growth. Approximately, PAD affects 8 to 12 million people in the United States, especially in those over 50. Out of these, 6.5 million over the age of 40 are diagnosed with PAD. Atherectomy devices provide a minimally invasive approach to remove arterial plaque as it is an important alternative in vascular interventions. The device enhances blood flow and reduces symptoms such as leg pain and fatigue. By directly cutting away or vaporizing the plaque, these devices help restore arterial patency, significantly improving patient outcomes in individuals with severe forms of PAD.

Technological Advancements

Major atherectomy devices innovations include the appearance of directionally controlled devices and high-frequency rotational technologies, which have continued to improve the effectiveness and safety of these devices. For instance, a 2020 study suggests that orbital atherectomy (which sands down plaque) effectively opens up blocked leg arteries 90 percent of the time, while laser atherectomy achieves similarly improved blood flow 76 percent of the time. These improvements in patient outcome and surgeon preference for these devices are propelling the growth of the atherectomy devices. In a multicenter study of 172 patients, Jetstream use had a 99% device success, and six-month and 12-month clinically-driven, target-lesion revascularization rates of 15% and 26%, respectively; with a one-year restenosis rate of 38% based on duplex imaging.

Expansion into Emerging Markets

Prominent key players are focusing on emerging economies where healthcare infrastructure development and growing healthcare spending is focused, thereby creating new opportunities for the key players in the market. For instance, the emerging markets of Brazil, Russia, India, China, and South Africa (BRICS) are increasingly shaping the landscape of the global health sector demand and supply for medical goods and services. Health spending as a percentage of GDP in 2030 is projected as - Brazil, 8.4%; Russia, 5.2%; India, 3.5%; China, 5.9%; South Africa, 10.4%. The penetration into these markets is enabled by realization of more advanced treatment alternatives, thus expanding the global footprint of atherectomy devices.

Atherectomy Devices Market Segmentation:

Breakup by Product:

  • Directional Atherectomy Devices
  • Orbital Atherectomy Devices
  • Photo-Ablative Atherectomy Devices
  • Rotational Atherectomy Devices
  • Support Devices

Directional Atherectomy Devices accounts for the majority of the market share

Directional atherectomy devices are created to precisely eliminate atherosclerotic plaque from obstructed arteries. These instruments provide the possibility of accurate control, which reduces vessel wall trauma, an important aspect for patient safety and recovery. Their ability to treat complex lesions in multiple vessel sizes makes them to be favoured by vascular specialists leading to the growth of the product segment. The capability of the devices to collect and remove plaque during the procedure sets these devices apart and is in a number of clinical situations preferable.

Breakup by Application:

  • Peripheral Vascular
  • Cardiovascular
  • Neurovascular

Peripheral Vascular accounts for the majority of the market share

The use of atherectomy devices in the treatment of peripheral vascular diseases is important because of the growing prevalence of PAD. Such devices play a key role in reestablishing the blood flow in leg arteries thus help to relieve the symptoms such as pain and mobility problems. The demand in this segment is determined by minimally invasive character of the procedure which allows short recovery period and lower risks of complications in comparison to conventional surgery making patient outcomes and treatment efficiencies higher.

Breakup by End User:

  • Hospitals
  • Ambulatory Surgery Centers
  • Research Laboratories and Academic Institutes

Hospitals accounts for the majority of the market share

Hospitals are the main users of atherectomy devices because these procedures are very complex and need advanced infrastructure and highly trained healthcare professionals. The growth of the segment is followed by the growth of the number of vascular surgeries conducted in hospitals, fueled by investments into advanced technologies and in the training programs of health providers. Ability of hospitals to offer all types of care including post-operative requirements also helps in making them the dominant subject in the market.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America dominates the market

The report has also provided a comprehensive analysis of all the major markets which include North America (United States, Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others); Latin America (Brazil, Mexico, Others), and Middle East and Africa. According to the report, North America was the largest market for atherectomy devices.

North America is the largest market for atherectomy because of high prevalence of cardiovascular diseases, developed healthcare system and the key market players in the region. The United States is the biggest market in this region because of the favourable reimbursement scenarios, clinical trials, and solid governmental support for research and development in advanced medical devices. The commitment of the region to application of new healthcare solutions is driving the market growth.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have been provided. Some of the major market players in the atherectomy devices market include Abbott Laboratories, Avinger, B. Braun Melsungen AG, Biomerics, Biotronik, Boston Scientific Corporation, C.R. Bard (Becton, Dickinson and Company), Cardinal Health, Koninklijke Philips N.V., Medtronic, Minnetronix Inc., Straub Medical AG (Becton, Dickinson and Company), and Terumo Corporation.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • There is a dynamic market in atherectomy devices with the use of evolving strategies by major players in pursuit to grow their market share and to satisfy the increasing demand for minimally invasive surgery alternatives. One of these approaches is technical oriented, which is to say that the companies invest significantly in R&D to improve their devices that become therefore more efficient and safer. The second common event is strategic alliances and collaborations that support knowledge sharing and better distribution channels. In addition, mergers and acquisitions are common enabling companies to expand their product portfolios and geographical coverage. Approvals by regulatory bodies play an important role here as the companies are trying to meet tough norms that guarantee the efficiency and safety of their products in many markets.

Key Questions Answered in This Report

  • 1.What was the size of the global atherectomy devices market in 2024?
  • 2.What is the expected growth rate of the global atherectomy devices market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global atherectomy devices market?
  • 4.What are the key factors driving the global atherectomy devices market?
  • 5.What is the breakup of the global atherectomy devices market based on the product?
  • 6.What is the breakup of the global atherectomy devices market based on the application?
  • 7.What is the breakup of the global atherectomy devices market based on the end user?
  • 8.What are the key regions in the global atherectomy devices market?
  • 9.Who are the key players/companies in the global atherectomy devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Atherectomy Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Directional Atherectomy Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Orbital Atherectomy Devices
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Photo-Ablative Atherectomy Devices
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Rotational Atherectomy Devices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Support Devices
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Peripheral Vascular
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiovascular
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurovascular
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgery Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research Laboratories and Academic Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Avinger
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 B. Braun Melsungen AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Biomerics
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Biotronik
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Boston Scientific Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 C.R. Bard (Becton, Dickinson and Company)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Cardinal Health Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Koninklijke Philips N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Medtronic
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Minnetronix Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Straub Medical AG (Becton, Dickinson and Company)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Terumo Corporation
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis